Innosphere re-ups with diabetic ulcer gel developer

Innosphere Ventures Fund bought in again on GelSana Therapeutics Inc. An earlier backing funded product development for the start-up’s therapeutic gels … This second seed-stage buy-in will accelerate research work, prepare a U.S. Food and Drug Administration submission and begin to build a pipeline of products … GelSana’s hydrogels aim to improve healing of diabetic ulcers and other wounds: closing cuts and sores faster, growing stronger skin and enabling controlled delivery of healing therapies … A product prototype was aimed at diabetic foot ulcers but “we believe the unique properties of GelSana’s hydrogels may have much larger applicability in wound healing,” founder and CEO Melissa Krebs said … read more